2019 Advisory Board

 

 

Cell and Gene Advisory Board

 

Andre Choulika, CEO, Cellectis Andre Choulika 
CEO
Cellectis

Dmitry Kuzmin, Managing Partner, 4BIO Capital Dmitry Kuzmin
Managing Partner
4BIO Capital 

Eric Soller, Vice President of Corporate Development & Strategy, BlueRock Therapeutics Eric Soller 
VP of Corporate Development & Strategy
BlueRock Therapeutics

Jaap Jan Boelens, Pediatrician - Oncologist / Immunologist, ISCT Regional Vice-President, Europe 2018 – 2020 Jaap Jan Boelens
Pediatrician - Oncologist / Immunologist
ISCT Regional VP, Europe 2018 – 2020 

Mark Lowdell, European President, ISCT; Professor of Cell and Tissue Therapy, UCL Mark Lowdell
European President, ISCT ; Professor of Cell and Tissue Therapy
UCL

Robert Beckman, Managing Partner, The Channel Group; Director of Business Development, Orgenesis Robert Beckman 
Managing Partner, The Channel Group ; Director of Business Development
Orgenesis

Sven Kili, Head of Cell & Gene Therapy Development, GSK Sven Kili 
Head of Cell & Gene Therapy Development
GSK

Michela Gabaldo, Head of Alliance Management & Regulatory Affairs, Fondazione Telethon Michela Gabaldo
Head of Alliance Management & Regulatory Affairs
Fondazione Telethon

David Morrow, Programme Manager, EATRIS David Morrow
Programme Manager
EATRIS

Miguel Forte, Chief Executive Officer, Zelluna Immunotherapy Miguel Forte
CEO
Zelluna Immunotherapy 

Mark Sawicki, Chief Commercial Officer, Cryoport Mark Sawicki 
Chief Commercial Officer
Cryoport

Bill Milligan, SVP, Corporate Development & Business Development, Steminent Biotherapeutics Inc. Bill Milligan
SVP, Corporate Development & Business Development
Steminent Biotherapeutics

Jacqueline Barry, Chief Clinical Officer, Cell and Gene Therapy Catapult Jacqueline Barry
Chief Clinical Officer
Cell and Gene Therapy Catapult 

TBC: Annie Hubert, Director, European Public Policy, Alliance for Regenerative Medicine Annie Hubert  
Director, European Public Policy 
Alliance for Regenerative Medicine  

 

 
 

 

Bioprocessing Advisory Board

 

  

Ohad Karnieli, Chair, Process and Product Development Subcommittee, ISCT; CEO & Co-Founder, ATVIO Biotechnology Bo Kara   
Head Process Development, Cell Gene Therapy CMC, GSK

Mitchel Sivilotti, Chief Operating Officer, CCRM James Miskin  
CTO 
Oxford Biomedica

Steven Pincus, Associate Vice President Virology and Analytical Methods Development, Fujifilm Diosynth Biotechnology Qasim Rafiq
Senior Lecturer (Associate Professor), Bioprocessing of Regenerative, Cellular and Gene Therapies, Department of Biochemical Engineering 
UCL

 

 
 

  

Ohad Karnieli, Chair, Process and Product Development Subcommittee, ISCT; CEO & Co-Founder, ATVIO Biotechnology Ohad Karnieli  
Chair, Process and Product Development Subcommittee, ISCT ; CEO & Co-Founder,  ATVIO Biotechnology

Mitchel Sivilotti, Chief Operating Officer, CCRM Mitchel Sivilotti 
Chief Operating Officer 
CCRM

Steven Pincus, Associate Vice President Virology and Analytical Methods Development, Fujifilm Diosynth Biotechnology Steven Pincus
Associate VP Virology and Analytical Methods Development 
Fujifilm Diosynth Biotechnology

 

 
 

 

Stem Cells and Regenerative Medicine Advisory Board

 

Alain Vertès, Managing Director, NxR Biotechnologies Alain Vertès
Managing Director
NxR Biotechnologies

Claudia Mitchell, Chief Executive Officer, Universal Cells Inc.

Claudia Mitchell 
Chief Executive Officer
Universal Cells Inc.

Norio Nakatsuji, Professor Emeritus, Kyoto University & Chief Advisor, Stem Cell & Device Laboratory, Inc Norio Nakatsuji 
Professor Emeritus, Kyoto University & Chief Advisor
Stem Cell & Device Laboratory, Inc

Stephen Badylak, Professor, Department of Surgery, Director, McGowan Center of Pre-Clinical Studies, Deputy Director, McGowan Institute for Regenerative Medicine (MIRM) Stephen Badylak 
Professor, Department of Surgery, Director, McGowan Center of Pre-Clinical Studies, Deputy Director, McGowan Institute for Regenerative Medicine ( MIRM )

Susan Solomon, CEO and Co-Founder, New York Stem Cell Foundation Susan Solomon
CEO and Co-Founder
New York Stem Cell Foundation 

 
 
 

There are two parts to the World Advanced Therapies & Regenerative Medicine Congress: a conference and an exhibition featuring solutions for pharma and biotech.

There is a registration fee to attend the conferences. To visit the exhibition is free.

TO SPONSOR / EXHIBIT

Erica Baeta 
+44 (0)207 092 1152 
erica.baeta@terrapinn.com

TO SPEAK

Jessica Robinson 
t/ +44 (0)207 092 1150 
jessica.robinson@terrapinn.com

TO REGISTER

Issa Mauthoor 
+44 (0)207 092 1257 
issa.mauthoor@terrapinn.com